4//SEC Filing
Cavanaugh Stefanie L. 4
Accession 0001688530-24-000002
CIK 0000926617other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:05 PM ET
Size
7.8 KB
Accession
0001688530-24-000002
Insider Transaction Report
Form 4
Cavanaugh Stefanie L.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-09-30−5,938→ 17,812 total→ Common Stock (5,938 underlying) - Exercise/Conversion
Common Stock
2024-09-30+5,938→ 60,914 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0001688530
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:05 PM ET
- Size
- 7.8 KB